Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

Hepatology

Volumn 50, Issue 2, 2009, Pages 424-433

  Gao, Bo ^a   Duan, Zhijian ^a   Xu, Wei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Immunology Division   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEPTIDES AND PROTEINS; SPROUTY PROTEIN; TRIPARTITE MOTIF CONTAINING PROTEIN 22; UNCLASSIFIED DRUG; CORE PROTEIN; REPRESSOR PROTEIN; TRIM22 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE LOCATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RING FINGER MOTIF; VIRUS CORE; VIRUS INHIBITION; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HELA CELL; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HEPATITIS B VIRUS; HUMANS; INTERFERONS; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RING FINGER DOMAINS; TRANSFECTION; VIRAL CORE PROTEINS; VIRUS REPLICATION;

EID: 68949189335     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23011     Document Type: Article

References (33)

1. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004;350:1118-1129. (Pubitemid 38298992)
2. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68.
3. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269-7272. (Pubitemid 40677357)
4. Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. HEPATOLOGY 2006;43:1364-1374. (Pubitemid 43980116)
5. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004;303:1829.
6. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005;3:799-808. (Pubitemid 41518740)
7. Ozato K, Shin DM, Chang TH, Morse HC 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 2008;8:849-860.
8. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004;427:848-853.
9. Kaiser SM, Malik HS, Emerman M. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science 2007;316:1756-1758. (Pubitemid 46988552)
10. Barr SD, Smiley JR, Bushman FD. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 2008;4:e1000007.
11. Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de The H, Chelbi-Alix MK. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 2001;20:3495-3505. (Pubitemid 32634356)
12. Wolf D, Goff SP. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 2007;131:46-57. (Pubitemid 47498526)
13. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. EMBO J 2001;20:2140-2151. (Pubitemid 32410584)
14. Sawyer SL, Emerman M, Malik HS. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog 2007;3:e197.
15. Tissot C, Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 1995;270:14891-14898.
16. Bouazzaoui A, Kreutz M, Eisert V, Dinauer N, Heinzelmann A, Hallenberger S, et al. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 2006;356:79-94. (Pubitemid 44750026)
17. Obad S, Olofsson T, Mechti N, Gullberg U, Drott K. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. J Interferon Cytokine Res 2007;27:857-864. (Pubitemid 350036595)
18. Deng YJ, Huang ZX, Zhou CJ, Wang JW, You Y, Song ZQ, et al. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. Mol Immunol 2006;43:1497-1507. (Pubitemid 43356391)
19. Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, et al. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 2006;118:1954-1962.
20. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91. (Pubitemid 32368030)
21. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004;101:6669-6674. (Pubitemid 38586032)
22. Christman JK, Gerber M, Price PM, Flordellis C, Edelman J, Acs G. Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A 1982;79:1815-1819. (Pubitemid 12088518)
23. Duan Z, Gao B, Xu W, Xiong S. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem Biophys Res Commun 2008;374:502-506.
24. Raney AK, Milich DR, Easton AJ, McLachlan A. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol 1990;64:2360-2368. (Pubitemid 20148484)
25. Pugh JC, Yaginuma K, Koike K, Summers J. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol 1988;62:3513-3516.
26. Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P, et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 2007;179:26-30. (Pubitemid 46986512)
27. Asaoka K, Ikeda K, Hishinuma T, Horie-Inoue K, Takeda S, Inoue S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem Biophys Res Commun 2005;338:1950-1956. (Pubitemid 41643112)
28. Orimo A, Tominaga N, Yoshimura K, Yamauchi Y, Nomura M, Sato M, et al. Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. Genomics 2000;69:143-149. (Pubitemid 30783131)
29. Wolf D, Hug K, Goff SP. TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc Natl Acad Sci U S A 2008;105:12521-12526.
30. Lin WJ, Li J, Lee YF, Yeh SD, Altuwaijri S, Ou JH, et al. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. J Biol Chem 2003;278:9353-9360. (Pubitemid 36800422)
31. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005;79:5548-5556. (Pubitemid 40548223)
32. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007;446:916-920. (Pubitemid 46633167)
33. Hong SJ, Chae H, Lardaro T, Hong S, Kim KS. Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b. Biochem Biophys Res Commun 2008;368:650-655.